As Johnson & Johnson continues to face thousands of suits alleging that feminine hygiene use of the firm’s talc-based Johnson’s Baby Powder and related products caused plaintiffs’ ovarian cancer, FDA will be conducting its own research into scientific issues under debate.
The agency is in the process of finalizing a review of published literature to identify data gaps, according to a...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?